$ATI

ATI (ATI) Q2 2026 Earnings Call Transcript

ATI reported Q2 2026 results in an earnings call. Revenue rose 11% to $1,261.1 million, with adjusted EBITDA up 37% to $284.4 million and margin expanding to 22.6%. Backlog reached a record $4.4 billion. Adjusted EPS was $1.23. Full-year 2026 guidance: adjusted EBITDA $1.135B-$1.185B and adjusted EPS $4.90-$5.18.

Original reporting
Published Aug 13, 2026, 7:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 7:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ATI (ATI) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ATIBullishHigh
01

Why it matters

Traders can update models using the disclosed Q2 results, raised FY2026 guidance, and the $1B five-year naval nuclear contract renewal, while monitoring deferred revenue and qualification timing that can shift shipments and cash flows.

02

Market read

Raised full-year guidance, record backlog, and a renewed naval nuclear contract are concrete catalysts for estimate revisions, while deferred revenue and extended lead times add near-term execution uncertainty.

03

What to watch

Working-capital initiatives (customer consignment for forging input material) and the balance between Specialty Energy capacity allocation versus naval nuclear orders could affect cash conversion and segment mix more than headline EBITDA.

Relevance 9/10Novelty 9/10Timing: post-call, for estimate revisions and near-term positioning ahead of next quarterly print

Background

ATI’s Q2 2026 earnings call highlights margin expansion across AA&S and HPMC, record backlog, and capacity investments tied to nickel and titanium production.

Company-level read

Ticker impact

$ATIBullishHigh confidence
Context

ATI guided FY2026 adjusted EBITDA to $1.135B-$1.185B and EPS to $4.90-$5.18, citing margin expansion and record $4.4B backlog.

Expected impact

Bias toward upward price pressure into the next earnings/estimate cycle, with volatility risk around deferred revenue and capacity qualification timing.

Evidence & confidence

The article discloses multiple new, decision-relevant datapoints: beat vs prior guidance on adjusted EBITDA, record backlog, and materially higher full-year guidance plus a $1B naval nuclear contract renewal. It also flags $30M-$40M deferred revenue and extended lead times, which can temper timing of cash conversion.

Market effects

Strength in aerospace and defense specialty alloys, plus nickel and titanium capacity expansion, may reinforce demand expectations for high-purity metals and qualified manufacturing supply chains.

No specific regional macro or policy catalyst beyond ATI’s Mexico facility and capacity buildout.

Defense and nuclear supply chain visibility (naval nuclear contract renewal) can influence broader expectations for Western qualified producers of specialty metals.

Counterpoint

Raised guidance may be partially timing-driven, with qualification-related shipment deferrals ($30M-$40M) and long lead times (12 months nickel alloys, 20 months premium titanium) increasing execution risk.

Key entities

  • ATI

    Advanced specialty metals producer reporting Q2 2026 results and raising FY2026 guidance.

  • Kimberly Fields

    CEO who discussed margin drivers, deferred revenue from qualification timing, and production throughput improvements.

  • James Foster

    CFO who discussed working-capital strategy including customer consignment for forging input material.

Related articles

$ATIMed

How Investors Are Reacting To ATI (ATI) Record Backlog And Raised Guidance

ATI Inc. raised its 2026 adjusted EBITDA and free cash flow guidance, citing record backlog and strong aerospace and defense demand. The company's updated outlook includes high teens defense growth, reinforcing its long-cycle thesis. ATI's share price is up 64% year-to-date, outpacing its industry group. Key risks include execution challenges and softer demand in industrial and medical sectors.

$ATIMed

ATI Shares Surge 64% YTD: What's Driving the Momentum?

ATI Inc. shares have surged 64% year to date, outperforming the aerospace-defense industry and S&P 500. The company reports strong aerospace and defense demand, a record backlog, and improved profitability. Q2 2026 jet-engine revenue rose 13%, defense sales increased 36% to $162M, and adjusted EBITDA grew 37% to $284.4M. ATI raised its 2026 adjusted EBITDA outlook to $1.135-$1.185B and adjusted free cash flow guidance to $550-$600M.

$ATIMed

4 Top Aerospace & Defense Stocks to Consider as America Commemorates 9/11

Four aerospace and defense stocks (ATI, DCO, IA, LOAR) are highlighted as Strong Buys by Zacks, with strong Q2 earnings and raised guidance. ATI reported $1.26B in sales (+10% YoY), record backlog of $4.4B, and raised 2026 EPS guidance. DCO saw record revenue of $224.5M (+11% YoY) and adjusted EPS of $1.18 (+34% YoY). IA reported $26.7M in sales (+11% YoY) and doubled adjusted EPS to $0.33. LOAR posted $171.6M in sales (+39% YoY) and raised 2026 EPS outlook.

$ATIMed

Extended Strategic Agreements to Support Management’s Full-Year 2026 Guidance Raise for ATI Inc. (ATI)

ATI Inc. (NYSE:ATI) raised its 2026 guidance after Q2 revenue rose 11% YoY to $1.26B, with adjusted EBITDA at $284.4M. The company secured long-term supply deals with BWX Technologies and Boeing, supporting its bullish outlook. However, risks include customer concentration and raw material cost volatility. Analysts remain bullish, with a consensus target price of $255.

$ATIMedAI 9/10

ATI’s (ATI) Record Backlog And Raised Guidance Signal Bigger Ambitions

ATI Inc. (NYSE:ATI) reported Q2 sales of $1.26B, up 11% YoY, with net income rising 50% to $151M. The company raised its full-year 2026 outlook, citing strong demand in aerospace and defense. ATI's backlog reached a record $4.4B, up 18% YoY. CEO Kimberly Fields noted demand outpacing supply, and the company repurchased $50M in shares. However, margins in one segment slipped, and debt increased to fund growth.

$ATIMed

Here's How Much a $1000 Investment in ATI Made 10 Years Ago Would Be Worth Today

ATI Inc., a Pittsburgh-based specialty materials producer, restructured in 2013 and 2020, focusing on High-Performance Materials & Components and Advanced Alloys & Solutions. In Q1 2026, earnings beat estimates but revenues missed. The company benefits from aerospace and defense demand but faces risks from production ramps and supply-chain issues.